Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.

Toshiji Kanayama(Mitsubishi Group (Japan)), Susumu Mizogami, Yuki Kimura(Jichi Medical University), Yuka Hayashi(National Center For Child Health and Development), Y Tamao, K Iseki
Journal of Pharmacology and Experimental Therapeutics
December 1, 1990
Cited by 3


Related Papers